The NRG Oncology trial findings have led to the establishment of a new acceptable practice standard for hypofractioned post-prostatectomy radiation therapy.

Published Date: 20 Mar 2024

HYPORT was found to be superior to COPORT in the Phase III NRG Oncology NRG-GU003 clinical trial, which compared the two types of post-prostatectomy radiation.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Stem Cell Selection Unneeded for SSc Transplant Therapy?

2.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

3.

Rural-urban disparities seen in cervical cancer

4.

Obesity linked to subsequent neoplasms in childhood cancer survivors

5.

New policy review highlights the importance of health-related quality of life in advanced cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot